1-(3-苯丙基)-2-硫脲 | 93168-20-8

• 物质功能分类: 化学试剂 - 有机试剂 - 硫脲
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(3-苯丙基)-2-硫脲
• 英文名称: N-(3-Phenylpropyl)thiourea
• 英文别名: 1-(3-phenylpropyl)thiourea；(3-Phenyl-propyl)-thioharnstoff；N-(3-Phenyl-propyl)-thioharnstoff；(3-phenyl-propyl)-thiourea；(γ-Phenyl-propyl)-thioharnstoff；1-(3-Phenylpropyl)-2-thiourea；3-phenylpropylthiourea
• CAS: 93168-20-8
• 化学式: C₁₀H₁₄N₂S
• 分子量: 194.301
• InChiKey: AGWZOAHAJCELJQ-UHFFFAOYSA-N

物化性质

• 熔点：
  111 °C
• 沸点：
  329.6±35.0 °C(Predicted)
• 密度：
  1.124±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  70.1
• 氢给体数：
  2
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  T
• 安全说明：
  S22,S36/37
• 危险类别码：
  R22
• 危险品运输编号：
  UN 2811
• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  1-(3-苯丙基)-2-硫脲 在 三甲基铝 、 氯化铵 作用下， 以 丙酮 、 甲苯 为溶剂， 生成 4-[2-(3-phenylpropyl)aminothiazol-4-yl]-5-methylthiothiophene-2-carboxamidine
  参考文献：
  名称：

  Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors

  摘要：

  The serine protease urokinase (uPa) has been implicated in the progression of both breast and prostate cancer. Utilizing structure based design, the synthesis of a series of substituted 4-[2-amino- 1,3-thiazolyl]-thiophene-2-carboxamidine is described. Further optimization of this series by substitution of the terminal amine yielded urokinase inhibitors with excellent activities. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00102-0
• 作为产物：
  描述：

  3-苯基-1-丙胺盐酸盐 在 氨 、 碳酸氢钠 作用下， 以 甲醇 、 氯仿 为溶剂， 反应 12.5h， 生成 1-(3-苯丙基)-2-硫脲
  参考文献：
  名称：

  Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors

  摘要：

  The serine protease urokinase (uPa) has been implicated in the progression of both breast and prostate cancer. Utilizing structure based design, the synthesis of a series of substituted 4-[2-amino- 1,3-thiazolyl]-thiophene-2-carboxamidine is described. Further optimization of this series by substitution of the terminal amine yielded urokinase inhibitors with excellent activities. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00102-0

文献信息

• Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: Synthesis, pharmacological evaluation, and cross-target QSAR studies
  作者：Herman D. Lim、Enade P. Istyastono、Andrea van de Stolpe、Giuseppe Romeo、Silvia Gobbi、Marjo Schepers、Roger Lahaye、Wiro M.B.P. Menge、Obbe P. Zuiderveld、Aldo Jongejan、Rogier A. Smits、Remko A. Bakker、Eric E.J. Haaksma、Rob Leurs、Iwan J.P. de Esch

  DOI：10.1016/j.bmc.2009.04.007

  日期：2009.6

  olyl)propyl]isothiourea) binds to both the human histamine H3 receptor (H3R) and H4 receptor (H4R). In this paper, we describe the synthesis and pharmacological characterization of a series of clobenpropit analogs, which vary in the functional group adjacent to the isothiourea moiety in order to study structural requirements for H3R and H4R ligands. The compounds show moderate to high affinity for

  先前的研究表明，clobenpropit（N-（4-氯苄基）-S- [3-（4（5）-咪唑基丙基）丙基]异硫脲）与人组胺H 3受体（H 3 R）和H 4受体均结合（H 4 R）。在本文中，我们描述了一系列clobenpropit类似物的合成和药理学表征，它们在与异硫脲部分相邻的官能团中有所不同，以研究H 3 R和H 4 R配体的结构要求。这些化合物对人的H 3 R和H 4均显示中等至高亲和力此外，与异硫脲部分连接的官能团的变化调节了配体在H 4 R的内在活性，范围从中性拮抗作用到完全激动作用。为了解释H 3 R和H 4 R的亲和力，已生成QSAR模型。
• [EN] ANTIVIRAL COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS ANTIVIRAUX ET LEUR UTILISATION
  申请人：UNIV DEGLI STUDI DI SIENA

  公开号：WO2019175436A1

  公开（公告）日：2019-09-19

  The present invention relates to compounds of formula (I), their use as medicaments, in particular as broad spectrum antiviral agents, their combination with a further antiviral agent and relative pharmaceutical compositions. In particular, the compounds of the invention are useful in the treatment of a disease caused by an enveloped virus.

  本发明涉及式(I)的化合物，它们作为药物的用途，特别是作为广谱抗病毒剂，以及与另一种抗病毒剂的组合和相关的药物组合物。特别是，本发明的化合物在治疗由包膜病毒引起的疾病方面是有用的。
• Platelet Aggregation Inhibiting and Anticoagulant Effects of Oligoamines, XXII: Bisoxazol-, Bisimidazol-, Bisthiazol- and Oligo-1,2,4-thiadiazolimines
  作者：Klaus Rehse、Antje Martens

  DOI：10.1002/ardp.19933260706

  日期：——

  for their antiplatelet and anticoagulant activities. The most potent compound was the tris‐thiadiazole derivative 18m which inhibited the aggregation of platelets induced by collagen at a concentration of 10 μmol/L by 50 percent (Born‐test). No anticoagulant effects (Quick‐test) were observed up to 400 μmol/L. In the thiazolamine series combined antiplatelet and anticoagulant activities were seen.

  一个介离子4,4'-丙烯-双-恶唑-5-亚胺（5），两个2,2'-间-亚苯基-双-咪唑-4-亚胺（9a，b），五个4,4'-苯-双-（和三）-噻唑-2-胺（13a、b、14a-c）和 14 3,3'-苯-双-（和三）-1,2,4-噻二唑亚胺（18a-o）合成并测定了它们的抗血小板和抗凝活性。最有效的化合物是三噻二唑衍生物 18m，它在 10 μmol/L 的浓度下抑制了 50% 的胶原蛋白诱导的血小板聚集（Born 试验）。在高达 400 μmol/L 时未观察到抗凝作用（快速测试）。在噻唑胺系列中可以看到抗血小板和抗凝活性的结合。
• METHODS OF DEGRADING ORGANIC POLLUTANTS AND PREVENTING OR TREATING MICROBE USING Bi2S3-CdS PARTICLES
  申请人：Imam Abdulrahman Bin Faisal University

  公开号：US20200102228A1

  公开（公告）日：2020-04-02

  Methods of synthesizing Bi 2 S 3 —CdS particles in the form of spheres as well as properties of these Bi 2 S 3 —CdS particles are described. Methods of photocatalytic degradation of organic pollutants employing these Bi 2 S 3 —CdS particles and methods of preventing or reducing microbial growth on a surface by applying these Bi 2 S 3 —CdS particles in the form of a solution or an antimicrobial product onto the surface are also specified.

  本文描述了合成球形Bi2S3-CdS颗粒的方法以及这些颗粒的性质。还介绍了利用这些Bi2S3-CdS颗粒进行光催化降解有机污染物的方法，以及通过将这些Bi2S3-CdS颗粒以溶液或抗微生物产品的形式涂布在表面上来防止或减少微生物生长的方法。
• Phenylpropanoic acid derivatives
  申请人：Yasuma Tsuneo

  公开号：US20070155808A1

  公开（公告）日：2007-07-05

  The present invention provides a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, a drug for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof have unexpectedly superior GPR40 receptor agonist activity and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful drugs for the prophylaxis or treatment of GPR40 receptor related conditions or diseases in mammals.

  本发明提供了一种新型化合物，具有GPR40受体功能调节作用，可用作胰岛素分泌剂，用于预防或治疗糖尿病等药物。化合物由式（I）表示，其中每个符号如规范中所定义，其盐和前药具有意外的优越的GPR40受体激动剂活性，并显示出卓越的药物产品特性，如稳定性等。因此，它们可以作为安全有效的药物，用于哺乳动物中预防或治疗与GPR40受体相关的疾病或病症。